Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("FURUTA, Takahisa")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 33

  • Page / 2
Export

Selection :

  • and

Influence of inflammatory cytokine polymorphisms on eradication rates of Helicobacter pyloriSUGIMOTO, Mitsushige; FURUTA, Takahisa; YAMAOKA, Yoshio et al.Journal of gastroenterology and hepatology. 2009, Vol 24, Num 11, pp 1725-1732, issn 0815-9319, 8 p.Article

Short Report: Elevated Levels of Vascular Endothelial Growth Factor (VEGF) and Soluble Vascular Endothelial Growth Factor Receptor (VEGFR)-2 in Human MalariaFURUTA, Takahisa; KIMURA, Mikio; WATANABE, Naohiro et al.The American journal of tropical medicine and hygiene. 2010, Vol 82, Num 1, pp 136-139, issn 0002-9637, 4 p.Article

Pharmacologic Aspects of Eradication Therapy for Helicobacter pylori InfectionFURUTA, Takahisa; GRAHAM, David Y.Gastroenterology clinics of North America. 2010, Vol 39, Num 3, issn 0889-8553, vii-viii, 465-480 [18 p.]Article

Effect of high-dose lansoprazole on intragastic pH in subjects who are homozygous extensive metabolizers of cytochrome P4502C19FURUTA, Takahisa; SHIRAI, Naohito; FANG XIAO et al.Clinical pharmacology and therapeutics. 2001, Vol 70, Num 5, pp 484-492, issn 0009-9236Article

Effect of genotypic differences in interleukin-1 beta on gastric acid secretion in japanese patients infected with Helicobacter pyloriFURUTA, Takahisa; SHIRAI, Naohito; TAKASHIMA, Misako et al.The American journal of medicine. 2002, Vol 112, Num 2, pp 141-143, issn 0002-9343Article

Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazoleFURUTA, Takahisa; SHIRAI, Naohito; YAMADA, Masami et al.Clinical pharmacology and therapeutics. 2002, Vol 72, Num 4, pp 453-460, issn 0009-9236, 8 p.Article

Effects of genotypic differences in CYP2C19 status on cure rates for helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillinFURUTA, Takahisa; SHIRAI, Naohito; TAKASHIMA, Misako et al.Pharmacogenetics (London). 2001, Vol 11, Num 4, pp 341-348, issn 0960-314XArticle

Resistance of Helicobacter pylori to quinolones and clarithromvcin assessed bv genetic testing in JapanYAMADE, Mihoko; SUGIMOTO, Mitsushige; UOTANI, Takahiro et al.Journal of gastroenterology and hepatology. 2011, Vol 26, Num 9, pp 1457-1461, issn 0815-9319, 5 p.Article

Determination of mutations of the 23S rRNA gene of Helicobacter pylori by allele specific primer-polymerase chain reaction methodNAKAMURA, Akiko; FURUTA, Takahisa; SHIRAI, Naohito et al.Journal of gastroenterology and hepatology. 2007, Vol 22, Num 7, pp 1057-1063, issn 0815-9319, 7 p.Article

Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in japanFURUTA, Takahisa; EL-OMAR, Emad M; FANG XIAO et al.Gastroenterology (New York, NY. 1943). 2002, Vol 123, Num 1, pp 92-105, issn 0016-5085Article

Guggulsterone Suppresses Bile Acid-induced and Constitutive Caudal-related Homeobox 2 Expression in Gut-derived Adenocarcinoma CellsYAMADA, Takanori; OSAWA, Satoshi; HAMAYA, Yasushi et al.Anticancer research. 2010, Vol 30, Num 6, pp 1953-1960, issn 0250-7005, 8 p.Article

Initial 48-hour acid inhibition by intravenous infusion of omeprazole, famotidine, or both in relation to cytochrome P450 2C19 genotype statusSUGIMOTO, Mitsushige; FURUTA, Takahisa; SHIRAI, Naohito et al.Clinical pharmacology and therapeutics. 2006, Vol 80, Num 5, pp 539-548, issn 0009-9236, 10 p.Article

Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjectsSUGIMOTO, Mitsushige; FURUTA, Takahisa; SHIRAI, Naohito et al.Journal of gastroenterology and hepatology. 2007, Vol 22, Num 9, pp 1443-1449, issn 0815-9319, 7 p.Article

Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in JapanSUGIMOTO, Mitsushige; FURUTA, Takahisa; SHIRAI, Naohito et al.Cancer epidemiology, biomarkers & prevention. 2006, Vol 15, Num 10, pp 1929-1934, issn 1055-9965, 6 p.Article

Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cellsFURUTA, Takahisa; UEDA, Takahiro; AUNE, Gregory et al.Cancer research (Baltimore). 2002, Vol 62, Num 17, pp 4899-4902, issn 0008-5472, 4 p.Article

Modified allele-specific primer-polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycinFURUTA, Takahisa; SOYA, Yoshihiro; FUJIOKA, Toshio et al.Journal of gastroenterology and hepatology. 2007, Vol 22, Num 11, pp 1810-1815, issn 0815-9319, 6 p.Article

Role of angiotensinogen gene polymorphism on Helicobacter pylori infection-related gastric cancer risk in JapaneseSUGIMOTO, Mitsushige; FURUTA, Takahisa; SHIRAI, Naohito et al.Carcinogenesis (New York. Print). 2007, Vol 28, Num 9, pp 2036-2040, issn 0143-3334, 5 p.Article

High-dose rabeprazole/amoxicillin therapy as the second-line regimen after failure to eradicate H. pylori by triple therapy with the usual doses of a proton pump inhibitor, clarithromycin and amoxicillinFURUTA, Takahisa; SHIRAI, Naohito; FANG XIAO et al.Hepato-gastroenterology. 2003, Vol 50, Num 54, pp 2274-2278, issn 0172-6390, 5 p.Article

The Dual Therapy with 4 Times Daily Dosing of Rabeprazole and Amoxicillin as the 3rd Rescue Regimen for Eradication of H. pyloriFURUTA, Takahisa; SUGIMOTO, Mitsushige; KODAIRA, Chise et al.Hepato-gastroenterology. 2010, Vol 57, Num 102-103, pp 1314-1319, issn 0172-6390, 6 p.Article

Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapySHIRAI, Naohito; SUGIMOTO, Mitsushige; KODAIRA, Chise et al.European journal of clinical pharmacology. 2007, Vol 63, Num 8, pp 743-749, issn 0031-6970, 7 p.Article

Fr901469, a novel antifungal antibiotic from an unidentified Fungus No.11243. II. In vitro and in vivo activitiesFUJIE, Akihiko; IWAMOTO, Toshiro; OKUHARA, Masakuni et al.Journal of antibiotics (Tokyo. 1968). 2000, Vol 53, Num 9, pp 920-927, issn 0021-8820Article

Comparison of acid inhibition with standard dosages of proton pump inhibitors in relation to CYP2C19 genotype in JapaneseSUGIMOTO, Mitsushige; SHIRAI, Naohito; NISHINO, Masafumi et al.European journal of clinical pharmacology. 2014, Vol 70, Num 9, pp 1073-1078, issn 0031-6970, 6 p.Article

Trastuzumab Has Opposing Effects on SN-38-induced Double-strand Breaks and Cytotoxicity in HER2-positive Gastric Cancer Cells Depending on Administration SequenceYAMADE, Mihoko; SUGIMOTO, Mitsushige; FURUTA, Takahisa et al.Anticancer research. 2012, Vol 32, Num 1, pp 105-114, issn 0250-7005, 10 p., aArticle

Serum Pepsinogens as an Early Diagnostic Marker of H. pylori EradicationSHIRAI, Naohito; FURUTA, Takahisa; KODAIRA, Makoto et al.Hepato-gastroenterology. 2008, Vol 55, Num 82-83, pp 486-490, issn 0172-6390, 5 p.Article

Different effects of polymorphisms of tumor necrosis factor-alpha and interleukin-1 beta on development of peptic ulcer and gastric cancerSUGIMOTO, Mitsushige; FURUTA, Takahisa; SHIRAI, Naohito et al.Journal of gastroenterology and hepatology. 2007, Vol 22, Num 1, pp 51-59, issn 0815-9319, 9 p.Article

  • Page / 2